Drug intelligence / Profile preview

krypton (81mKr)

Development stage
Unknown
Lead developer
GE Healthcare
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Inhalation, Intravenous
01

Overview

Krypton Kr 81m is an approved radioactive diagnostic gas used primarily for pulmonary ventilation imaging. As a radioactive isotope of the noble gas krypton, it has an extremely short physical half-life of approximately 13.1 seconds, which allows for high-resolution imaging with minimal radiation exposure to the patient, as the gas is rapidly eliminated through exhalation. It is typically produced via a rubidium-81 (Rb-81) generator system. In clinical practice, it is often used in conjunction with pulmonary perfusion scintigraphy to diagnose pulmonary embolism and is also employed in the assessment of regional ventilation heterogeneity in patients with chronic obstructive pulmonary disease (COPD). The agent can be administered as an inhaled gas or as an isotonic solution for continuous infusion in lung, myocardial, and cerebral perfusion studies.

Brand names
MPI KRYPTON 81M GENERATOR
Other names
krypton-81mkrypton81mkrypton 81mKr-81mKr81mKr 81m81mKryptonKrypton Kr 81m

Beyond the preview

Go deeper on krypton (81mKr).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on krypton (81mKr).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call